Valuation: NeoGenomics, Inc.

Market Cap 2.32B 2.08B 1.91B 1.73B 3.24B 220B 3.3B 22.79B 9.15B 116B 8.71B 8.52B 365B P/E 2026 *
-65.8x
P/E 2027 * -73.9x
Enterprise Value 2.32B 2.08B 1.91B 1.73B 3.24B 220B 3.3B 22.79B 9.15B 116B 8.71B 8.52B 365B EV / Sales 2026 *
2.87x
EV / Sales 2027 * 2.62x
Free-Float
95.44%
Yield 2026 *
-
Yield 2027 * -
1 day-3.07%
1 week+6.04%
Current month-5.34%
1 month-7.26%
3 months+13.82%
6 months+93.97%
Current year+47.79%
1 week 16.61
Extreme 16.61
18.15
1 month 15.41
Extreme 15.41
20.15
Current year 7.06
Extreme 7.065
20.15
1 year 7.06
Extreme 7.065
20.15
3 years 4.72
Extreme 4.72
21.22
5 years 4.72
Extreme 4.72
47.13
10 years 4.72
Extreme 4.72
61.57
Manager TitleAgeSince
Chief Executive Officer 65 31/03/2025
President 54 31/03/2025
Director of Finance/CFO 57 01/03/2026
Director TitleAgeSince
Chairman 64 06/10/2021
Director/Board Member 63 18/07/2017
Director/Board Member 69 14/07/2020
Date Insider Type Main position Quantity % Market Cap. Importance
01/10/26 Exercice

Chairperson

42,035 0.0327%
01/09/26 Tax

General Counsel

-2,692 0.0021%
21/08/26 Exercice

Chairperson

67,272 0.0524%
Change 5-day change 1-year change 3-year change Capi.($)
-3.07%+6.04%+69.07%+27.70% 2.3B
-0.09%-4.48%+11.97%+36.14% 116B
-1.02%+1.26%+1.02%+110.04% 104B
-4.98%+3.22%+114.87%+982.85% 62.85B
-1.84%+9.54%+45.64%+81.64% 29.89B
+0.96%+3.74%-7.04%+92.23% 29.55B
-0.43%+3.51%+44.08%+97.23% 27.83B
+0.99%+0.97%+30.65%+414.40% 21.79B
-0.72%+5.53%-18.98%-7.55% 20.66B
0.00%-1.75%-4.85%+31.49% 17.09B
Average -0.82%+3.72%+28.64%+186.62% 43.1B
Weighted average by Cap. -0.63%+2.07%+26.55%+219.68%

Financials

2026 *2027 *
Net sales 808M 724M 666M 603M 1.13B 76.74B 1.15B 7.94B 3.19B 40.37B 3.03B 2.97B 127B 886M 794M 730M 662M 1.24B 84.17B 1.26B 8.71B 3.5B 44.28B 3.33B 3.26B 140B
Net income -31.5M -28.21M -25.95M -23.51M -43.95M -2.99B -44.78M -309M -124M -1.57B -118M -116M -4.96B -40.59M -36.35M -33.43M -30.29M -56.63M -3.85B -57.69M -399M -160M -2.03B -152M -149M -6.39B
Net Debt - -
Projected Income Statement - Annual - NeoGenomics, Inc.
Logo NeoGenomics, Inc.
NeoGenomics, Inc. is a cancer diagnostics company specializing in cancer genetics testing and information services. The Company offers comprehensive oncology-focused testing menus across the cancer continuum, serving oncologists, pathologists, hospital systems, academic centers, and pharmaceutical firms with diagnostic and predictive testing to help them diagnose and treat cancer. Its services include clinical cancer testing, interpretation and consultative services, molecular and NGS testing, comprehensive technical and professional services offering, clinical trials and research, validation laboratory services, and oncology data solutions. It operates a network of laboratories for full-service sample processing and analysis services throughout the United States and a full-service sample-processing laboratory in Cambridge, United Kingdom. Its testing services include Cytogenetics, Fluorescence In-Situ Hybridization (FISH), Flow cytometry, Molecular testing and others.
Employees
2,500
Date Price Change Volume
30/10/26 US$17.38 -3.07% 1,464,109
29/10/26 US$17.93 -0.33% 3,758,970
28/10/26 US$17.99 +4.17% 2,578,609
27/10/26 US$17.27 +3.48% 2,753,351
26/10/26 US$16.69 +0.60% 1,302,439
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AA
MarketScreener Ratings - NeoGenomics, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
17.93USD
Average target price
23.33USD
Spread / Average Target
+30.14%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - NeoGenomics, Inc.